Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

2.

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings.

Pīrāgs V, El Damassy H, Dąbrowski M, Gönen MS, Račická E, Martinka E, Giaconia J, Stefanski A; B001 Study Investigators.

Int J Clin Pract. 2012 Nov;66(11):1033-41. doi: 10.1111/j.1742-1241.2012.03001.x. Erratum in: Int J Clin Pract. 2013 Jun;67(6):e1.

PMID:
23067027
3.

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.

Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G; ROADMAP Trial Investigators.

N Engl J Med. 2011 Mar 10;364(10):907-17. doi: 10.1056/NEJMoa1007994.

4.

Systematic measurement of fall-out in Czechoslovakia up to 1961.

SANTHOLZER W, MACKU G, PODZIMEK J.

Nature. 1961 Nov 4;192:398-400. No abstract available.

PMID:
14497041
5.

The semi-quantitative determination of cholesterol and cholesteryl esters by paper chromatography.

MICHALEC C, JIRGL V, PODZIMEK J.

Experientia. 1957 Jun 15;13(6):242. No abstract available.

PMID:
13447942

Supplemental Content

Loading ...
Write to the Help Desk